We have an updated report [Version - 2024] available. Kindly sign up to get the sample of the report.
all report title image

TISSUE PLASMINOGEN ACTIVATOR MARKET ANALYSIS

Tissue Plasminogen Activator Market, By Drug Type (Alteplase, Reteplase, Tenecteplase), By Application (Ischemic Stroke, Myocardial Infarction, Pulmonary Embolism, Thrombolysis, Others), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Sep 2023
  • Code : CMI2469
  • Pages :141
  • Formats :
      Excel and PDF
  • Industry : Biotechnology

Tissue Plasminogen Activator MarketSize and Trends

Global tissue plasminogen activator market is estimated to be valued at US$ 2.58 Bn in 2023, and is expected to exhibit a CAGR of 5.2% during the forecast period (2023-2030).

Figure 1. Global Tissue Plasminogen Activator Market Share (%), By Drug Type, 2023

Market Trends

Global Tissue Plasminogen Activator Market - Key Trends

  • Increasing Number of Pipeline Products: Increasing number of pipeline products for the treatment of acute ischemic stroke is expected to drive the global tissue plasminogen activator market in the near future. In December 2022, University of Calgary, a research university in Canada, completed the investigational clinical trials study on alteplase in comparison with tenecteplase for the treatment of acute ischemic stroke. Tenecteplase was found to be safe and effective.

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.